Suppr超能文献

全球人类心房颤动导管消融术的方法、疗效及安全性调查。

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

作者信息

Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Packer Douglas, Skanes Allan

机构信息

Arrhythmia and Electrophysiology Center, Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy.

出版信息

Circulation. 2005 Mar 8;111(9):1100-5. doi: 10.1161/01.CIR.0000157153.30978.67. Epub 2005 Feb 21.

Abstract

BACKGROUND

The purpose of this study was to conduct a worldwide survey investigating the methods, efficacy, and safety of catheter ablation (CA) of atrial fibrillation (AF).

METHODS AND RESULTS

A detailed questionnaire was sent to 777 centers worldwide. Data relevant to the study purpose were collected from 181 centers, of which 100 had ongoing programs on CA of AF between 1995 and 2002. The number of patients undergoing this procedure increased from 18 in 1995 to 5050 in 2002. The median number of procedures per center was 37.5 (range, 1 to 600). Paroxysmal AF, persistent AF, and permanent AF were the indicated arrhythmias in 100.0%, 53.0%, and 20.0% of responding centers, respectively. The most commonly used techniques were right atrial compartmentalization between 1995 and 1997, ablation of the triggering focus in 1998 and 1999, and electrical disconnection of multiple pulmonary veins between 2000 and 2002. Of 8745 patients completing the CA protocol in 90 centers, of whom 2389 (27.3%) required >1 procedure, 4550 (52.0%; range among centers, 14.5% to 76.5%) became asymptomatic without drugs and another 2094 (23.9%; range among centers, 8.8% to 50.3%) became asymptomatic in the presence of formerly ineffective antiarrhythmic drugs over an 11.6+/-7.7-month follow-up period. At least 1 major complication was reported in 524 patients (6.0%).

CONCLUSIONS

The findings of this survey provide a picture of the variable and evolving methods, efficacy, and safety of CA for AF as practiced in a large number of centers worldwide and may serve as a guide to clinicians considering therapeutic options in patients suffering from this arrhythmia.

摘要

背景

本研究旨在进行一项全球调查,以探究心房颤动(AF)导管消融(CA)的方法、疗效及安全性。

方法与结果

向全球777个中心发送了一份详细问卷。从181个中心收集了与研究目的相关的数据,其中100个中心在1995年至2002年期间开展了AF的CA项目。接受该手术的患者数量从1995年的18例增加至2002年的5050例。每个中心手术的中位数为37.5例(范围为1至600例)。阵发性AF、持续性AF和永久性AF分别是100.0%、53.0%和20.0%的应答中心所指的心律失常类型。最常用的技术在1995年至1997年为右心房分隔,1998年和1999年为触发灶消融,2000年至2002年为多条肺静脉电隔离。在90个中心完成CA方案的8745例患者中,2389例(27.3%)需要进行>1次手术,4550例(52.0%;各中心范围为14.5%至76.5%)在未使用药物的情况下无症状,另外2094例(23.9%;各中心范围为8.8%至50.3%)在使用先前无效的抗心律失常药物的情况下,经过11.6±7.7个月的随访期后无症状。524例患者(6.0%)报告至少发生1次主要并发症。

结论

本次调查结果呈现了全球众多中心实施的AF的CA方法、疗效及安全性的变化和发展情况,可为考虑对患有这种心律失常的患者进行治疗选择的临床医生提供指导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验